These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30427060)

  • 1. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity.
    Kumar NP; Moideen K; Bhootra Y; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Immunology; 2019 Mar; 156(3):249-258. PubMed ID: 30427060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment.
    Kumar NP; Moideen K; Viswanathan V; Shruthi BS; Sivakumar S; Menon PA; Kornfeld H; Babu S
    BMC Infect Dis; 2018 Jul; 18(1):345. PubMed ID: 30045688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
    BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidity.
    Kumar NP; Moideen K; Viswanathan V; Sivakumar S; Hissar S; Kornfeld H; Babu S
    J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100237. PubMed ID: 33997311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Cytokine; 2020 Jan; 125():154824. PubMed ID: 31472402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.
    Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
    Tuberculosis (Edinb); 2016 Dec; 101():191-200. PubMed ID: 27865391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden.
    Pavan Kumar N; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Shanmugam S; Hissar S; Kornfeld H; Babu S
    Front Cell Infect Microbiol; 2019; 9():335. PubMed ID: 31632923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
    Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
    J Infect; 2017 Jan; 74(1):10-21. PubMed ID: 27717783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity.
    Kumar NP; Moideen K; Dhakshinraj SD; Banurekha VV; Nair D; Dolla C; Kumaran P; Babu S
    Immunology; 2015 Oct; 146(2):243-50. PubMed ID: 26095067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean platelet volume (MPV): new diagnostic indices for co-morbidity of tuberculosis and diabetes mellitus.
    Xu F; Qu S; Wang L; Qin Y
    BMC Infect Dis; 2021 May; 21(1):461. PubMed ID: 34016046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity.
    Fernández RDV; Díaz A; Bongiovanni B; Gallucci G; Bértola D; Gardeñez W; Lioi S; Bertolin Y; Galliano R; Bay ML; Bottasso O; D'Attilio L
    Front Endocrinol (Lausanne); 2020; 11():126. PubMed ID: 32265833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of chemokines IP-10, IL-8 and SDF-1 serve as good biomarkers for diabetes-tuberculosis nexus.
    Aravindhan V; Kevinkumar V; Dhamodharan U; Viswanathan V
    J Diabetes Complications; 2018 Sep; 32(9):857-862. PubMed ID: 30025786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes.
    Shivakoti R; Dalli J; Kadam D; Gaikwad S; Barthwal M; Colas RA; Mazzacuva F; Lokhande R; Dharmshale S; Bharadwaj R; Kagal A; Pradhan N; Deshmukh S; Atre S; Sahasrabudhe T; Kakrani A; Kulkarni V; Raskar S; Suryavanshi N; Chon S; Gupte A; Gupta A; Gupte N; Arriaga MB; Fukutani KF; Andrade BB; Golub JE; Mave V
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106398. PubMed ID: 31726221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon.
    Mascia C; Vita S; Zuccalà P; Marocco R; Tieghi T; Savinelli S; Rossi R; Iannetta M; Pozzetto I; Furlan C; Mengoni F; Mastroianni CM; Vullo V; Lichtner M
    PLoS One; 2017; 12(6):e0179400. PubMed ID: 28636655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.
    Degner NR; Wang JY; Golub JE; Karakousis PC
    Clin Infect Dis; 2018 Jan; 66(2):198-205. PubMed ID: 29325084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
    Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
    BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity.
    Kumar NP; Banurekha VV; Nair D; Dolla C; Kumaran P; Babu S
    Tuberculosis (Edinb); 2018 Jan; 108():127-135. PubMed ID: 29523313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.
    Kumar NP; Banurekha VV; Nair D; Kumaran P; Dolla CK; Babu S
    Tuberculosis (Edinb); 2015 Dec; 95(6):707-712. PubMed ID: 26354610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyl arginine, and insulin resistance in type 2 diabetic patients.
    Toupchian O; Sotoudeh G; Mansoori A; Nasli-Esfahani E; Djalali M; Keshavarz SA; Koohdani F
    J Clin Lipidol; 2016; 10(4):798-807. PubMed ID: 27578110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-classical circulating monocytes in severe obesity and obesity with uncontrolled diabetes: A comparison with tuberculosis and healthy individuals.
    Resende DP; da Costa AC; de Souza Rosa LP; Rodrigues AP; Santos ASEA; Cardoso CK; Sousa JD; Kipnis A; Silveira EA; Junqueira-Kipnis AP
    Tuberculosis (Edinb); 2019 Jan; 114():30-41. PubMed ID: 30711155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.